AVH 0.41% $2.42 avita medical inc.

AVH on NASDAQ, page-304

  1. 6,503 Posts.
    lightbulb Created with Sketch. 1892
    "I find it amusing when expenses go up, shareholders complain.
    Expenses go down, they still find excuses to complain."

    It's not the high operating costs that are the issue. It's the high costs that are supposed to drive strong revenue growth.... except with AVH, they spend truckloads of money but are only getting tepid sales growth. Yes, you need to spend money to make money... except at the moment they are just losing money without growing revenue.

    Growth companies are supposed to grow strongly. All I keep hearing here are excuses.

    Quarter on quarter growth for AVH was a measly .2%. Contrast that with PolyNovo which is also in the growth phase - achieved 33% quarter on quarter growth.

    Both companies need to address the challenges of growing sales in the Covid environment. One is still growing and meeting their sales target.
 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.42
Change
0.010(0.41%)
Mkt cap ! $160.4M
Open High Low Value Volume
$2.42 $2.45 $2.41 $562.3K 231.8K

Buyers (Bids)

No. Vol. Price($)
4 82002 $2.42
 

Sellers (Offers)

Price($) Vol. No.
$2.43 16 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.